NADH: ubiquinone oxidoreductase inhibitors block induction of ornithine decarboxylase activity in MCF-7 human breast cancer cells.
J C Rowlands, J E Casida
Index: Pharmacol. Toxicol. 83(5) , 214-9, (1998)
Full Text: HTML
Abstract
Rotenone is the classical inhibitor of NADH: ubiquinone oxidoreductase and its analogue deguelin is a potent inhibitor of 12-O-tetradecanoylphorbol 13-acetate (TPA)-induced ornithine decarboxylase mRNA steady state level and enzyme activity in mouse 308 cells (Gerhäuser et al. 1995). In MCF-7 human breast cancer cells, rotenone, deguelin and two structurally-unrelated miticides (pyridaben and fenazaquin) inhibit not only NADH: ubiquinone oxidoreductase but also induced ornithine decarboxylase activity with IC50 values of < 1 to 70 nM. Rotenone inhibits ornithine decarboxylase activity equally well as induced by TPA, insulin-like growth factor I and 17 beta-oestradiol. Pyridaben is the most potent of the four inhibitors not only for NADH: ubiquinone oxidoreductase activity (bovine heart enzyme) and TPA-induced ornithine decarboxylase activity and mRNA steady state level but also for TPA-induced reactive oxygen species. It is therefore proposed that NADH: ubiquinone oxidoreductase inhibitors block multiple and possibly reactive oxygen species-modulated pathways which regulate ornithine decarboxylase activity.
Related Compounds
Related Articles:
Side-effects of fenazaquin on a cellular model of Paramecium.
2009-01-01
[Commun. Agric. Appl. Biol. Sci. 74(1) , 129-35, (2009)]
Investigation in tea on fate of fenazaquin residue and its transfer in brew.
2006-04-01
[Food Chem. Toxicol. 44(4) , 596-600, (2006)]
2001-05-01
[Pest Manag. Sci. 57(5) , 443-8, (2001)]
Investigation in tea on fate of fenazaquin residue and its transfer in brew.
2004-03-01
[Food Chem. Toxicol. 42(3) , 423-8, (2004)]
Use of vancomycin hydrochloride for treatment of Clostridium difficile enteritis in Syrian hamsters.
1994-02-01
[Lab. Anim. Sci. 44(1) , 31-7, (1994)]